Kodiak Sciences (KOD) Accumulated Depreciation (2017 - 2025)
Kodiak Sciences (KOD) posted Accumulated Depreciation of $59.5 million for Q4 2025, up 44.13% on a QoQ basis from $41.3 million in Q4 2024, and up 44.13% year-over-year from $41.3 million in Q4 2024.
Kodiak Sciences (KOD) Accumulated Depreciation (2017 - 2025) Analysis & Trends
Kodiak Sciences' Accumulated Depreciation history runs 9 years deep, the most recent figure standing at $59.5 million for Q4 2025.
- Quarterly Accumulated Depreciation rose 44.13% year-over-year to $59.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $59.5 million (up 44.13% YoY) and the FY2025 annual result came in at $59.5 million, up 44.13% from the prior year.
- Accumulated Depreciation was $59.5 million for Q4 2025 at Kodiak Sciences, up from $41.3 million in the prior quarter.
- Across five years, Accumulated Depreciation topped out at $59.5 million in Q4 2025 and bottomed at $2.9 million in Q4 2021.
- A 5-year average of $26.6 million and a median of $22.6 million in 2023 frame the typical range for Accumulated Depreciation.
- Annual changes were most pronounced in 2021 — Accumulated Depreciation surged 35.44% — and 2023, when it surged 235.4%.
- Kodiak Sciences' Accumulated Depreciation stood at $2.9 million in 2021, then jumped by 128.79% to $6.7 million in 2022, then jumped by 235.4% to $22.6 million in 2023, then soared by 82.96% to $41.3 million in 2024, then soared by 44.13% to $59.5 million in 2025.
- Business Quant data shows KOD's Accumulated Depreciation at $59.5 million in Q4 2025, $41.3 million in Q4 2024, and $22.6 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Kodiak Sciences | 2.54 Bn | 2.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 59.47 Mn |
| Dec 31, 2024 | 41.26 Mn |
| Dec 31, 2023 | 22.55 Mn |
| Dec 31, 2022 | 6.72 Mn |
| Dec 31, 2021 | 2.94 Mn |
| Dec 31, 2020 | 2.17 Mn |
| Dec 31, 2019 | 1.77 Mn |
| Dec 31, 2018 | 1.69 Mn |
| Sep 30, 2018 | 1.82 Mn |
| Dec 31, 2017 | 1.45 Mn |